Wired |

You need more than rat tumors to prove phones cause cancer

UC Davis researchers offer a counterpoint to concerns a new study has raised.

UC San Francisco |

Hybrid cancer drug could be resistance-resistant

UCSF scientists find conjoined compounds deal double blow to resistant cancers in cells and mice.

UC Merced |

Cancer cell growth linked to nervous system in UC Merced study

Research shows cells with damaged DNA proliferate more in upper areas of the body and near brain tissue in flatworms.

UC San Francisco |

Laura Esserman named to TIME 100 list

UCSF oncologist at the forefront of breast cancer services named one of the most influential people in the world.

UC San Francisco |

UCSF cancer immunotherapy clinic offers unique studies of promising treatments

Cutting-edge therapies are helping patients keep cancer in check for years.

UCLA |

Microscope uses artificial intelligence to find cancer cells more efficiently

UCLA-invented device analyzes 36 million images per second and uses deep learning to identify rogue cells.

UC San Francisco |

UCSF, UCLA join collaboration to advance national cancer initiative

Renowned UCSF immunologist to head new Parker Institute for Cancer Immunotherapy.

UC San Diego |

Higher levels of vitamin D correspond to lower cancer risk

Levels of 40 ng/ml or greater can make the disease as much as 67 percent less likely, UC San Diego researchers find.

UC Davis |

Cancer gene twice as likely to be defective in children with autism

A tumor suppressor is found missing in many autistic children and their fathers by UC Davis researchers.

UC Santa Cruz Magazine |

Building a ladder to a cure

UC Santa Cruz researchers open a new front in the treatment of pediatric cancer.

UC Merced |

UC Merced researchers identify drug that could treat melanoma

Scientists discover a genetic activation among patients with skin cancer that could be suppressed by a new drug.

UC San Francisco |

Biden advances national cancer moonshot at UC San Francisco

The vice president meets with UC Berkeley and UCSF experts to discuss accelerating research and clinical trials.